naltrexone has been researched along with Postpartum Amenorrhea in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.79) | 18.7374 |
1990's | 15 (78.95) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Böttcher, B; Dörr, HG; Wildt, L | 1 |
Gamba, O; Gastaldi, M; Genazzani, AD; Genazzani, AR; Petraglia, F; Volpogni, C | 1 |
Brailly, S; Chanson, P; Couzinet, B; Schaison, G; Young, J | 1 |
de Wit, W; Schoemaker, J; Schoute, E | 1 |
Ferrarotti, M; Fornengo, R; Isolato, G; Manieri, C; Marolda, AR; Messina, M; Musso, MC; Pastorino, R | 1 |
Leyendecker, G; Rabenbauer, B; Sir-Petermann, T; Waibel-Treber, S; Wildt, L | 1 |
Leyendecker, G; Waibel-Treber, S; Wildt, L | 1 |
Leyendecker, G; Sir-Petermann, T; Waibel-Treber, S; Wildt, L | 1 |
Bauman, M; Bullen, BA; Evans, WJ; Henley, K; McArthur, JW; Pehrson, J; Skrinar, GS; Turnbull, BA; Turner, A | 1 |
Battaglia, C; Gastaldi, M; Genazzani, AD; Genazzani, AR; Petraglia, F; Surico, N; Volpe, A | 1 |
Aguzzoli, L; Bacchi Modena, A; Botticelli, G; Bresciani, D; Florio, P; Genazzani, AR; Nappi, RE; Petraglia, F; Villa, P | 1 |
Alba, F; Devoto, L; Kohen, P; Rivera, J; Sir, T | 1 |
Armeanu, MC; Berkhout, GM; Schoemaker, J | 1 |
Armeanu, MC; Berkhout, GM; Lambalk, CB; Schoemaker, J | 1 |
Armeanu, MC; Moss, RJ; Schoemaker, J | 1 |
Anserini, P; De Cecco, L; Remorgida, V; Salerno, E; Venturini, PL | 1 |
Divila, F; Presl, J | 1 |
Leyendecker, G; Wildt, L | 1 |
Huber, JC | 1 |
8 trial(s) available for naltrexone and Postpartum Amenorrhea
Article | Year |
---|---|
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea.
Topics: Administration, Oral; Amenorrhea; Body Mass Index; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Estrogens; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Naloxone; Naltrexone; Narcotic Antagonists; Progestins; Weight Loss | 1995 |
Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Topics: Adult; Amenorrhea; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Luteinizing Hormone; Naltrexone; Ovulation Induction; Pregnancy; Progesterone; Statistics, Nonparametric | 1995 |
Chronic naltrexone treatment induces desensitization of the luteinizing hormone pulse generator for opioid blockade in hyperprolactinemic patients.
Topics: Adult; Amenorrhea; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Naltrexone; Ovulation Induction; Pulsatile Flow; Time Factors | 1995 |
Naltrexone must not be considered a real therapy in functional hypothalamic amenorrhea. The results of a double blind controlled study.
Topics: Adolescent; Adult; Amenorrhea; Double-Blind Method; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamus; Luteinizing Hormone; Menstruation; Naltrexone; Placebos; Progesterone | 1993 |
Nalmefene enhances LH secretion in a proportion of oligo-amenorrheic athletes.
Topics: Adult; Amenorrhea; Analysis of Variance; Androstenedione; Dehydroepiandrosterone; Estradiol; Female; Humans; Luteinizing Hormone; Menstruation; Naltrexone; Narcotic Antagonists; Oligomenorrhea; Physical Education and Training; Pituitary Gland; Progesterone; Sports; Substance Withdrawal Syndrome; Thyrotropin; Thyroxine; Time Factors; Vagina | 1993 |
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea.
Topics: Amenorrhea; Female; Follicle Stimulating Hormone; Humans; Hypothalamus; Luteinizing Hormone; Naltrexone; Narcotic Antagonists; Neurosecretory Systems | 1995 |
Ovulation induction with a single-blind treatment regimen comparing naltrexone, placebo and clomiphene citrate in women with secondary amenorrhea.
Topics: Amenorrhea; Clomiphene; Female; Gonadal Steroid Hormones; Humans; Naltrexone; Ovulation; Ovulation Induction; Placebos | 1992 |
Naltrexone in functional hypothalamic amenorrhea and in the normal luteal phase.
Topics: Adult; Amenorrhea; Double-Blind Method; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Hypothalamic Diseases; Luteal Phase; Luteinizing Hormone; Menstrual Cycle; Naltrexone; Reference Values | 1990 |
11 other study(ies) available for naltrexone and Postpartum Amenorrhea
Article | Year |
---|---|
Naltrexone as a diagnostic tool to distinguish between hyperandrogenemic and hypothalamic ovarian failure in females with congenital adrenal hyperplasia due to 21-hydroxylase-deficiency (CAH).
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Amenorrhea; Female; Humans; Hyperandrogenism; Hypothalamic Diseases; Naltrexone; Narcotic Antagonists; Oligomenorrhea; Primary Ovarian Insufficiency; Young Adult | 2014 |
Opiate antagonist treatment of ovarian failure.
Topics: Adolescent; Adult; Amenorrhea; Blood Glucose; Endorphins; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hypothalamus; Insulin; Insulin Resistance; Luteinizing Hormone; Middle Aged; Naltrexone; Ovarian Diseases; Pregnancy | 1993 |
Pulsatile administration of gonadotrophin releasing hormone and oral administration of naltrexone in hypothalamic amenorrhoea.
Topics: Amenorrhea; Female; Gonadotropin-Releasing Hormone; Humans; Hypothalamic Diseases; Infertility, Female; Naltrexone; Ovulation; Periodicity; Pregnancy | 1993 |
Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy.
Topics: Adolescent; Adult; Amenorrhea; Female; Humans; Hypothalamic Diseases; Luteinizing Hormone; Naltrexone; Ovarian Diseases; Ovulation Induction; Pregnancy | 1993 |
Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women.
Topics: Adolescent; Adult; Amenorrhea; Exercise; Female; Hormones; Humans; Naltrexone; Pituitary Hormones; Steroids; Time Factors | 1992 |
[Ovulation induction by the chronic administration of naltrexone in a patient with secondary hypothalamic amenorrhea].
Topics: Adolescent; Amenorrhea; Female; Humans; Hypothalamic Diseases; Menstrual Cycle; Naltrexone; Ovulation Induction; Time Factors | 1992 |
Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment.
Topics: Activity Cycles; Adult; Amenorrhea; Anorexia Nervosa; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamus; Luteinizing Hormone; Naltrexone; Polycystic Ovary Syndrome; Prospective Studies; Radioimmunoassay | 1992 |
Effects of opioid antagonism with naltrexone on pulsatile luteinizing hormone secretion in women with hypothalamic amenorrhea in basal conditions and after discontinuation of treatment with pulsatile LHRH.
Topics: Adolescent; Adult; Amenorrhea; Endorphins; Female; Gonadotropin-Releasing Hormone; Humans; Hypothalamic Diseases; Luteinizing Hormone; Naltrexone; Pulsatile Flow | 1992 |
[The opiate antagonist, naltrexone, in the treatment of anovulation and premenstrual syndrome].
Topics: Amenorrhea; Anovulation; Female; Humans; Naltrexone; Premenstrual Syndrome | 1989 |
Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea.
Topics: Adult; Amenorrhea; Female; Humans; Hypothalamic Diseases; Luteal Phase; Luteinizing Hormone; Naltrexone; Ovulation Induction; Time Factors | 1987 |
[Clinical experiences with naltrexone].
Topics: Adolescent; Adult; Amenorrhea; Female; Humans; Hyperprolactinemia; Naltrexone; Prolactin | 1987 |